Skip to main content
. 2014 Nov 7;20(41):15358–15366. doi: 10.3748/wjg.v20.i41.15358

Table 4.

Prevalence of hepatitis B virus in our inflammatory bowel disease study vs in European studies

Loras 2009 (study 1) Chevaux 2010 (study 2) Our IBD study Study 1 vs our study (P value) Study 2 vs our study (P value)
Chronic HBV (HBsAg) 0.7% 0.95% 1.8% 0.070 0.159
Exposure to HBV (Anti-HBc Ab) 7.5% 2.50% 3.2% 0.006 0.313

IBD: Inflammatory bowel disease; HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen; anti-HBc Ab: Hepatitis B core antibodies.